Back to search
FDAFDA · Food and drugs·Recall number Z-2669-2014

Pedi-Pak Pedi-Syringe Filter 35 mL Monoject Syringe Rx Only Genesis BPS, LLC The intended use is to prepare and deliver small aliquots of filtered whole blood, red blood cells, platelets, plasma, and cryoprecipitate for pediatric and or neonatal transfusion.

Published September 24, 2014 · Recall initiated: July 17, 2014

Summary

FDA records medical device Class II recall Z-2669-2014, published September 24, 2014 and initiated July 17, 2014. Recalling firm: Genesis BPS, LLC.; Status: Terminated; Reported quantity: 4608 units; Lot: Cat #405-535MJ Lot # 3650-23970; 3650-24518; 3650-23477; 3650-23507; 3650-24331; 3650-24396; 3650-24486; 3650-25301. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Genesis BPS is recalling numerous devices since they did not notify the agency of its intent to introduce material changes.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Genesis BPS, LLC.
Distributor
Nationwide Distribution & Switzerland
Lot
Cat #405-535MJ Lot # 3650-23970; 3650-24518; 3650-23477; 3650-23507; 3650-24331; 3650-24396; 3650-24486; 3650-25301
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Pedi-Pak Pedi-Syringe Filter 35 mL Monoject Syringe Rx Only Genesis BPS, LLC The intended use is to prepare and deliver small aliquots of filtered whole blood, red blood cells, platelets, plasma, and cryoprecipitate for pediatric and or neonatal transfusion. recalled?

Yes. FDA published recall Z-2669-2014 on September 24, 2014. Reported hazard: Genesis BPS is recalling numerous devices since they did not notify the agency of its intent to introduce material changes.

What should I do if I have this product?

Voluntary: Firm initiated · Letter